Imipenem/Relebactam Ex Vivo Clearance during Continuous Renal Replacement Therapy.

CRRT clearance imipenem pharmacokinetics relebactam

Journal

Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404

Informations de publication

Date de publication:
29 Sep 2021
Historique:
received: 11 08 2021
revised: 22 09 2021
accepted: 25 09 2021
entrez: 23 10 2021
pubmed: 24 10 2021
medline: 24 10 2021
Statut: epublish

Résumé

(1) Purpose of this study: determination of adsorption and transmembrane clearances (CL

Identifiants

pubmed: 34680765
pii: antibiotics10101184
doi: 10.3390/antibiotics10101184
pmc: PMC8532761
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Merck
ID : 57387

Références

Expert Rev Anti Infect Ther. 2017 Jul;15(7):677-688
pubmed: 28571493
Crit Care. 2020 Feb 17;24(1):55
pubmed: 32066497
N Engl J Med. 2008 Jul 3;359(1):7-20
pubmed: 18492867
Am J Kidney Dis. 1993 Feb;21(2):172-9
pubmed: 8430678
J Antimicrob Chemother. 2013 Oct;68(10):2286-90
pubmed: 23696619
J Nephrol. 2015 Oct;28(5):623-31
pubmed: 25249467
Blood Purif. 2010;30(1):37-43
pubmed: 20588011
Antimicrob Agents Chemother. 2005 Jun;49(6):2421-8
pubmed: 15917542
Int J Infect Dis. 2019 Dec;89:55-61
pubmed: 31479762
Lancet Infect Dis. 2009 Apr;9(4):228-36
pubmed: 19324295
Blood Purif. 2018;46(3):214-219
pubmed: 30048960
Blood Purif. 2017;44(1):16-23
pubmed: 28237981
J Clin Pharmacol. 2018 Oct;58(10):1254-1265
pubmed: 29746711
Antimicrob Agents Chemother. 2012 Jul;56(7):3753-7
pubmed: 22526311
Blood Purif. 2009;28(4):348-53
pubmed: 19729904
Crit Care Med. 2019 Nov;47(11):e863-e871
pubmed: 31397714
Am J Kidney Dis. 2014 Jan;63(1):170-1
pubmed: 24145021
Clin J Am Soc Nephrol. 2016 Aug 8;11(8):1377-83
pubmed: 27197907
Pharmacotherapy. 2016 Dec;36(12):1229-1237
pubmed: 27862103
Antimicrob Agents Chemother. 1997 Dec;41(12):2640-5
pubmed: 9420033
ASAIO J. 1997 Jan-Feb;43(1):84-8
pubmed: 9116359
Ann Pharmacother. 2020 Jan;54(1):43-55
pubmed: 31342772
J Clin Pharmacol. 2016 Oct;56(10):1277-87
pubmed: 26919659
Blood Purif. 2006;24(5-6):548-54
pubmed: 17124423
Kidney Int. 2010 Aug;78(4):408-14
pubmed: 20505659
J Antimicrob Chemother. 2015;70(6):1804-11
pubmed: 25698772
Intensive Care Med. 2015 May;41(5):776-95
pubmed: 25792203
Blood Purif. 2015;40(1):66-71
pubmed: 26138225
Pharmacy (Basel). 2020 Feb 07;8(1):
pubmed: 32046092
Antimicrob Agents Chemother. 2015 Aug;59(8):5029-31
pubmed: 26014931
Crit Care Med. 2011 Jan;39(1):19-25
pubmed: 20890189
Pharm World Sci. 2005 Oct;27(5):371-5
pubmed: 16341743

Auteurs

Soo Min Jang (SM)

Department of Pharmacy Practice, Loma Linda University School of Pharmacy, Loma Linda, CA 92350, USA.

Lenar Yessayan (L)

Department of Medicine Division of Nephrology, Michigan Medicine, Ann Arbor, MI 48109, USA.

Michael Dean (M)

Chicago College of Osteopathic Medicine, Midwestern University, Downers Grove, IL 60515, USA.

Gabrielle Costello (G)

College of Human Medicine, Michigan State University, East Lansing, MI 49503, USA.

Ravi Katwaru (R)

Merck & Co., Kenilworth, NJ 07033, USA.

Bruce A Mueller (BA)

Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, MI 48109, USA.

Classifications MeSH